Angiotensin-converting enzyme inhibitor–associated elevations in serum creatinine: is this a cause for concern?
GL Bakris, MR Weir - Archives of internal medicine, 2000 - jamanetwork.com
Background Reducing the actions of the renin-angiotensin-aldosterone system with
angiotensin-converting enzyme inhibitors (ACEIs) slows nephropathy progression in patients with or …
angiotensin-converting enzyme inhibitors (ACEIs) slows nephropathy progression in patients with or …
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
…, A Tandon, NR Powe, NE Fink, JH Sadler, MR Weir… - Nature …, 2008 - nature.com
As end-stage renal disease (ESRD) has a four times higher incidence in African Americans
compared to European Americans, we hypothesized that susceptibility alleles for ESRD …
compared to European Americans, we hypothesized that susceptibility alleles for ESRD …
The evaluation of renal transplantation candidates: clinical practice guidelines
…, DN Rush, MA Vazquez, MR Weir - … : official journal of …, 2001 - pubmed.ncbi.nlm.nih.gov
… 1 , Charles B Cangro, Sundaram Hariharan, Dondald E Hricik, Ronald H Kerman, David
Roth, David N Rush, Miguel A Vazquez, Matthew R Weir; American Society of Transplantation …
Roth, David N Rush, Miguel A Vazquez, Matthew R Weir; American Society of Transplantation …
The frequency of hyperkalemia and its significance in chronic kidney disease
…, MF Moen, SL Seliger, MR Weir… - Archives of internal …, 2009 - jamanetwork.com
Background Hyperkalemia is a potential threat to patient safety in chronic kidney disease (CKD).
This study determined the incidence of hyperkalemia in CKD and whether it is …
This study determined the incidence of hyperkalemia in CKD and whether it is …
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified …
Background The Avoiding Cardiovascular Events through Combination Therapy in Patients
Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive …
Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive …
[HTML][HTML] Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
MR Weir, GL Bakris, DA Bushinsky… - … England Journal of …, 2015 - Mass Medical Soc
Background Hyperkalemia increases the risk of death and limits the use of inhibitors of the
renin–angiotensin–aldosterone system (RAAS) in high-risk patients. We assessed the safety …
renin–angiotensin–aldosterone system (RAAS) in high-risk patients. We assessed the safety …
Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the …
The challenges inherent in conducting accurate, clinically effective, and cost-effective
cardiac evaluations among transplantation candidates relate to the large size of the target …
cardiac evaluations among transplantation candidates relate to the large size of the target …
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study
GL Bakris, MR Weir, S Shanifar, Z Zhang… - Archives of internal …, 2003 - jamanetwork.com
Background Clinical trials of nephropathy in people with type 2 diabetes mellitus have not
examined the effects of systolic blood pressure (SBP) or pulse pressure (PP) on the time to end…
examined the effects of systolic blood pressure (SBP) or pulse pressure (PP) on the time to end…
The renin-angiotensin-aldosterone system: a specific target for hypertension management
MR Weir, VJ Dzau - American journal of hypertension, 1999 - academic.oup.com
Angiotensin II plays a central role in the regulation of systemic arterial pressure through its
systemic synthesis via the renin-angiotensin-aldosterone cascade. It acts directly on vascular …
systemic synthesis via the renin-angiotensin-aldosterone cascade. It acts directly on vascular …
Clinical course of polyoma virus nephropathy in 67 renal transplant patients
…, E Schweitzer, ST Bartlett, MR Weir - Journal of the …, 2002 - journals.lww.com
ABSTRACT. Polyoma virus (PV) can cause interstitial nephritis and lead to graft failure in renal
transplant recipients. The clinical course of patients with polyoma virus nephritis (PVN) is …
transplant recipients. The clinical course of patients with polyoma virus nephritis (PVN) is …